TCGA-CRC displayed that the group with a high expression of CILP2 was associated with a reduced survival rate in patients with CRC (https://www.proteinatlas.org/ENSG00000160161-CILP2/pathology/colorectal+cancer, Fig. S1). Here, CILP2 is linked to colorectal carcinoma.